This study is innovative in two aspects: first, it validated the diagnostic value of the combined detection of CA125, AFP, and CEA for gastric cancer; second, it confirmed the close association of CA125, AFP, and CEA with the prognosis of gastric cancer patients. Here, AFP is linked to gastric cancer.